Abdominal pain is a hallmark of many digestive disorders, including inflammatory bowel disease and irritable bowel syndrome.
News-Medical.Net on MSN
Innovative approaches target PAR2 receptor to alleviate gut pain
Abdominal pain is a hallmark of many digestive disorders, including inflammatory bowel disease and irritable bowel syndrome.
Ochsner Health addressed talent gaps by “Bringing the outside in and the inside up”, generating significant benefits for the ...
TipRanks on MSN
NRx Pharmaceuticals (NASDAQ: NRXP) Strengthens Pipeline with Dual Pathways for Ketamine-Based Therapies
Austin, Texas, United States, October 9th, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage ...
Researchers at Penn Medicine have identified specific brain circuits that are impacted by psilocybin—the active compound ...
LONDON and NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic ...
Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome ...
In a new study, older adults who received acupuncture had less pain and better mobility than those who got medication or physical therapy. A new clinical trial in older adults finds that acupuncture ...
If a toothpick had pierced the man's duodenum, it would completely explain all of the man's symptoms. He drank too much and ...
Stockhead on MSN
Health Check: Smiles all around as PainChek wins FDA clearance for its groundbreaking digital app
The US regulator has provided clearance for PainChek's digital app for pain detection, thus opening a US$100 million a year ...
You’re unlikely to open a medicine cabinet in the U.S. without seeing a bottle of Tylenol, the brand name of a pain reliever and fever reducer also sold generically as acetaminophen. A health care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results